User menu

Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer

Bibliographic reference Massard, Christophe ; Chi, Kim Nguyen ; Castellano, Daniel ; de Bono, Johann ; Gravis, Gwenaelle ; et. al. Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer. In: European Journal of Cancer, Vol. 76, p. 36-44 (2017)
Permanent URL http://hdl.handle.net/2078.1/185633